Jacqueline Shea
Vorstandsvorsitzender bei INOVIO PHARMACEUTICALS, INC.
Vermögen: 239 153 $ am 30.04.2024
Aktive Positionen von Jacqueline Shea
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 16.05.2022 | - |
| Vorstandsvorsitzender | 10.05.2022 | - | |
| Präsident | 10.05.2022 | - | |
| Geschäftsführer | 25.03.2019 | 10.05.2022 | |
Albert B. Sabin Vaccine Institute, Inc.
 Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Albert B. Sabin Vaccine Institute, Inc. creates solutions to health threats. It works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the pervasive health care challenges. The company was founded in 1993 and is headquartered in Washington, DC. | Direktor/Vorstandsmitglied | 13.08.2019 | - |
Karriereverlauf von Jacqueline Shea
Ehemalige bekannte Positionen von Jacqueline Shea
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Aeras Global TB Vaccine Foundation
 Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Direktor/Vorstandsmitglied | 01.04.2014 | 01.08.2015 |
| Vorstandsvorsitzender | 01.08.2015 | 01.12.2018 | |
| Geschäftsführer | 01.04.2014 | 01.08.2015 | |
| EMERGENT BIOSOLUTIONS INC. | Corporate Officer/Principal | 01.05.2013 | 01.03.2014 |
| The Oxford-Emergent Tuberculosis Consortium Ltd. | Corporate Officer/Principal | 01.01.2008 | 01.01.2013 |
Ausbildung von Jacqueline Shea
| The National Institute For Medical Research | Doctorate Degree |
| University of Bath | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Vereinigtes Königreich | 4 |
Operativ
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
| Chief Operating Officer | 2 |
Sektoral
| Commercial Services | 3 |
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| EMERGENT BIOSOLUTIONS INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Aeras Global TB Vaccine Foundation
Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Commercial Services |
Albert B. Sabin Vaccine Institute, Inc.
Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Albert B. Sabin Vaccine Institute, Inc. creates solutions to health threats. It works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the pervasive health care challenges. The company was founded in 1993 and is headquartered in Washington, DC. | Commercial Services |
| The Oxford-Emergent Tuberculosis Consortium Ltd. |
- Börse
- Insiders
- Jacqueline Shea
- Erfahrung
